Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amryt
Amryt
Biotech M&A is picking back up - here are the latest deals
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Flag link:
Pfizer's fortunes overshadow first-quarter dealmaking
Pfizer's fortunes overshadow first-quarter dealmaking
EP Vantage
M&A
Pfizer
Seagen
Sanofi
Provention Bio
AstraZeneca
CinCor
Chiesi
Amryt
Ipsen
Albireo
Flag link:
Go or no go? PDUFA resolutions eyed for J&J and Amryt
Go or no go? PDUFA resolutions eyed for J&J and Amryt
EP Vantage
FDA
JNJ
Legend Biotech
ciltacabtagene autoleucel
Amryt
Oleogel-S10
Flag link:
Epidermolysis bullosa gene therapies wait in the wings
Epidermolysis bullosa gene therapies wait in the wings
EP Vantage
epidermolysis bullosa
Amryt
Filsuvez
gene therapy
Flag link:
Maker of world's most expensive prescription drug flashes PhIII data for a potential fourth product
Maker of world's most expensive prescription drug flashes PhIII data for a potential fourth product
Endpoints
Amryt
clinical trials
episalvan
epidermolysis bullosa
Flag link:
